A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15561813

Download in:

View as

General Info

PMID
15561813